CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 3b, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Study to Compare Once Daily Nebulized Revefenacin With Spiriva Once Daily Delivered Via the HandiHaler® on Lung Function in Subjects With COPD and a Low PIFR
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03095456
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:47.038473+00:00
- Published At
- 2018-12-31T00:00:00+00:00
- Record Updated At
- 2022-02-24
- Results Posted At
- 2018-12-31
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Chronic Obstructive Pulmonary Disease, COPD", "Low Peak Inspiratory Flow Rate (PIFR)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-02-24"- protocolSection.identificationModule.nctId
"NCT03095456"- protocolSection.identificationModule.officialTitle
"A Phase 3b, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Study to Compare Once Daily Nebulized Revefenacin With Spiriva Once Daily Delivered Via the HandiHaler\u00ae on Lung Function in Subjects With COPD and a Low PIFR"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-12-31"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.